Skip navigation

Applying the Latest Innovations to Accelerate the Translation from Concept to Commercialization

March 26-27, 2018
  • Washington, DC

There has been a tremendous amount of progress in the development of cell and gene therapies, which would not be possible without the application of novel tools, technologies and techniques to develop the processes required to manufacture these revolutionary products. As such, CBI’s Bioprocessing Series is proud to present Optimization of Cell & Gene Therapy Production
A revolutionary event focused on the technical and process innovations that are now yielding clinical and commercial success and the collaborative, industry-wide effort to overcome the tremendous bioprocessing obstacles and bottlenecks facing this field.

Utilizing a single-track format, this event will serve as a platform to unite leading developers and end users to collectively tackle the specific process and production challenges in one room — Not separated into several tracks in a trade show-like setup. This streamlined format paves the way for a variety of interactive formats that encourage participation and maximize the conference experience for every attendee.

Together, as a community, we will share ideas, solutions and lessons learned to propel this field towards commercial sustainability through the optimization of:

  • Process Development
  • Process Characterization
  • Analytical Method Development
  • Potency Assay Development
  • Process Comparability and Tech Transfer
  • Standardization and Quality by Design (QbD)
  • Closed System Development
  • Unit Operations and Automation
  • Regulatory Pathways
  • Biopreservation

Optimization of Cell & Gene Therapy Production

Applying the Latest Innovations to Accelerate the Translation from Concept to Commercialization

There has been a tremendous amount of progress in the development of cell and gene therapies, which would not be possible without the application of novel tools, technologies and techniques to develop the processes required to manufacture these revolutionary products. As such, CBI’s Bioprocessing Series is proud to present Optimization of Cell & Gene Therapy Production
A revolutionary event focused on the technical and process innovations that are now yielding clinical and commercial success and the collaborative, industry-wide effort to overcome the tremendous bioprocessing obstacles and bottlenecks facing this field.

Utilizing a single-track format, this event will serve as a platform to unite leading developers and end users to collectively tackle the specific process and production challenges in one room — Not separated into several tracks in a trade show-like setup. This streamlined format paves the way for a variety of interactive formats that encourage participation and maximize the conference experience for every attendee.

Together, as a community, we will share ideas, solutions and lessons learned to propel this field towards commercial sustainability through the optimization of:

  • Process Development
  • Process Characterization
  • Analytical Method Development
  • Potency Assay Development
  • Process Comparability and Tech Transfer
  • Standardization and Quality by Design (QbD)
  • Closed System Development
  • Unit Operations and Automation
  • Regulatory Pathways
  • Biopreservation